| Financial Year |
March 31 2023 |
| Monetary Funds |
246,754,724.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
258,699,545.77 |
| Advances to Suppliers |
24,858,726.38 |
| Other Receivables |
13,831,916.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
715,880,361.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
18,724,585.53 |
| Other Current Assets |
2,159,295.55 |
| Total Current Assets |
1,341,487,817.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,006,029.95 |
| Long-term Equity Investment |
8,201,451.45 |
| Investment Properties |
-- |
| Fixed Assetes |
315,445,995.25 |
| Under-construction Projects |
1,880,458.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,601,743.55 |
| R&D expenses |
-- |
| Goodwill |
808,293.72 |
| Long-Term Deferred and Prepaid Expenses |
6,538,338.22 |
| Deferred Income Tax Assets |
65,606,794.11 |
| Other Non-Current Assets |
6,593,090.88 |
| Sub-Total of Non-Current Assets |
496,698,851.21 |
| Total Assets |
1,838,186,668.53 |
| Short-Term Loans |
279,369,508.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
115,376,190.19 |
| Accounts Payable |
313,772,218.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,347,337.78 |
| Taxes Payable |
5,966,810.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,637,806.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,174,892.05 |
| Other Current Liabilities |
18,969,119.82 |
| Sub-Total of Current Liabilities |
1,182,248,338.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
217,756.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
72,100,926.42 |
| Total Liabilities |
1,254,349,265.22 |
| Paid-In Capital(Or Share Stock) |
195,244,050.00 |
| Capital Surplus |
223,237,092.36 |
| Surplus Reserve |
35,863,968.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
128,164,795.39 |
| Minority Stockholder's Interest |
1,819,533.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
582,017,869.70 |
| Owner's Equity（Stockholder's Equity） |
583,837,403.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,838,186,668.53 |
